Mechanisms of ovarian steroid hormones and antioestrogens in the development of carcinomas of the breast and endometrium

Citation
Mw. Beckmann et al., Mechanisms of ovarian steroid hormones and antioestrogens in the development of carcinomas of the breast and endometrium, GEBURTSH FR, 60(2), 2000, pp. 71-76
Citations number
56
Categorie Soggetti
Reproductive Medicine
Journal title
GEBURTSHILFE UND FRAUENHEILKUNDE
ISSN journal
00165751 → ACNP
Volume
60
Issue
2
Year of publication
2000
Pages
71 - 76
Database
ISI
SICI code
0016-5751(200002)60:2<71:MOOSHA>2.0.ZU;2-P
Abstract
The ovarian steroid hormones (e.g., estrogen and progesterone) exert their many cellular and organ-specific effects via steroid-hormone receptors. Ste roid-hormon-dependent genes are stimulated by binding of the ligand-recepto r complex to the DNA binding site. Most steroid-hormone-receptors in the br east and endometrium are located in the cell nuclei. Additionally, non-geno mic effects are mediated by intracellular proteins. Cell activities such as proliferation, differentiation, division and apoptosis are regulated by pr oto-oncogenes, tumor suppressor genes and mutator genes. Normally various r egulatory mechanisms are in balance. Dysfunctions in regulatory mechanisms are key steps in the malignant transformation of cells in the breast or end ometrium. Thus, the effects of steroid homones or anti-estrogens such as ta moxifen or ralofixene can be obviated despite the presence of functional re ceptors.